GA2LEN NoE calls for more focus on allergies in FP7

The Network of Excellence (NoE) GA2LEN is urging policy makers to support the European Parliament's proposal to include allergic diseases in the health priorities of the Seventh Framework Programme (FP7).

While allergies are mentioned among the food research priorities in the European Commission's proposal, members of GA2LEN would like to see the wider allergy problem a top priority for health research. Only 8% of allergies in Europe are related to food.

"The absence of the wider allergy problem as a top concern in health research agenda threatens to compromise overall progress in the understanding of this complex condition," says the Network in a statement.

Allergies are a global problem, although the presentation and cause of the reactions vary. Researchers believe that the many different aspects of the condition, as well as its triggers, must be addressed if we are to gain a comprehensive understanding of allergic diseases as a whole.

Allergies can be fatal. According to the World Health Organization (WHO), asthma kills someone in Europe every hour. And the problem is becoming more widespread -one child in three is now allergic to something, and by 2015, half of all Europeans may be suffering from one or more allergic condition.

For sufferers, allergies can have a major impact of daily life. Children with allergic diseases miss days at school and must sometimes abstain from sport and other recreational activities, while breathing and skin problems dent the confidence of children and adults.

GA2LEN also highlights the financial costs of allergies, which estimates suggest amount to €100 billion per year.

The GA2LEN network brings together 26 allergy research centres around Europe with the aim of advancing diagnosis, prevention and treatment of allergic diseases. In recent months, a European database of comparable, longitudinal epidemiological studies, known has cohorts, has been completed. This should help scientists to conduct a more reliable analysis of the multiple genetic and environmental factors causing allergies.

For further information on GA2LEN, please visit:
http://www.ga2len.net

Copyright ©European Communities, 2006
Neither the Office for Official Publications of the European Communities, nor any person acting on its behalf, is responsible for the use, which might be made of the attached information. The attached information is drawn from the Community R&D Information Service (CORDIS). The CORDIS services are carried on the CORDIS Host in Luxembourg – http://cordis.europa.eu.int. Access to CORDIS is currently available free-of-charge.

Most Popular Now

AI-Powered CRISPR could Lead to Faster G…

Stanford Medicine researchers have developed an artificial intelligence (AI) tool to help scientists better plan gene-editing experiments. The technology, CRISPR-GPT, acts as a gene-editing “copilot” supported by AI to help...

Groundbreaking AI Aims to Speed Lifesavi…

To solve a problem, we have to see it clearly. Whether it’s an infection by a novel virus or memory-stealing plaques forming in the brains of Alzheimer’s patients, visualizing disease processes...

AI Spots Hidden Signs of Depression in S…

Depression is one of the most common mental health challenges, but its early signs are often overlooked. It is often linked to reduced facial expressivity. However, whether mild depression or...

ChatGPT 4o Therapeutic Chatbot 'Ama…

One of the first randomized controlled trials assessing the effectiveness of a large language model (LLM) chatbot 'Amanda' for relationship support shows that a single session of chatbot therapy...

AI Tools Help Predict Severe Asthma Risk…

Mayo Clinic researchers have developed artificial intelligence (AI) tools that help identify which children with asthma face the highest risk of serious asthma exacerbation and acute respiratory infections. The study...

AI Model Forecasts Disease Risk Decades …

Imagine a future where your medical history could help predict what health conditions you might face in the next two decades. Researchers have developed a generative AI model that uses...

AI Model Indicates Four out of Ten Breas…

A project at Lund University in Sweden has trained an AI model to identify breast cancer patients who could be spared from axillary surgery. The model analyses previously unutilised information...

AI Distinguishes Glioblastoma from Look-…

A Harvard Medical School–led research team has developed an AI tool that can reliably tell apart two look-alike cancers found in the brain but with different origins, behaviors, and treatments. The...

Overcoming the AI Applicability Crisis a…

Opinion Article by Harry Lykostratis, Chief Executive, Open Medical. The government’s 10 Year Health Plan makes a lot of the potential of AI-software to support clinical decision making, improve productivity, and...

Smart Device Uses AI and Bioelectronics …

As a wound heals, it goes through several stages: clotting to stop bleeding, immune system response, scabbing, and scarring. A wearable device called "a-Heal," designed by engineers at the University...

Dartford and Gravesham Implements Clinis…

Dartford and Gravesham NHS Trust has taken a significant step towards a more digital future by rolling out electronic test ordering using Clinisys ICE. The trust deployed the order communications...